• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. HERO GRAFT; VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. HERO GRAFT; VASCULAR GRAFT Back to Search Results
Model Number HERO 1001
Device Problem Insufficient Information (3190)
Patient Problem Complaint, Ill-Defined (2331)
Event Type  Injury  
Event Description
According to a poster presentation entitled, "the hemodialysis reliable outflow (hero) graft: a cost-consequence analysis, and patient case series" by inston et al.Implantations (august and october 2013) for three patients with end stage failing vascular access, aged 39 to 51 years and with 6 to 13 previous catheter lines, were reviewed retrospectively.The paper identified a minor transient complication, a device repositioning managed as a day case.
 
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Manufacturer Narrative
According to a poster presentation entitled, "the hemodialysis reliable outflow (hero) graft: a cost-consequence analysis, and patient case series" by (b)(6) et al.Implantations ((b)(6) 2013) for three patients with end stage failing vascular access, aged 39 to 51 years and with 6 to 13 previous catheter lines, were reviewed retrospectively.The paper identified a minor transient complication, a device repositioning managed as a day case.Multiple attempts were made to gain additional information from mr.(b)(6); however all were unsuccessful.Device migration is listed on the hero graft ifu as a potential vascular graft and catheter complication.Directions on how to place the device are provided in the ifu.Adequate precautions and warnings are provided in the ifu.Without operative notes or farther details about the device repositioning it is not clear how this event occurred and if there were any surgical deviations from the specified methodology.It is unclear what impact this event had on the patient.The case was treated within the span of one day, but the intervention used to treat the patient is unclear.The root cause for the reported event is unknown.Device migration is listed on the hero graft ifu as a potential vascular graft and catheter complication.Directions on how to place the device are provided in the ifu.This event represents a known potential complication of the hero graft which is outlined in the device's ifu.There is no indication that an error or deficiency occurred at cryolife and the ifu adequately communicates risk.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
 
Event Description
According to a poster presentation entitled, "the hemodialysis reliable outflow (hero) graft: a cost-consequence analysis, and patient case series" by inston et al.Implantations ((b)(6) 2013) for three patients with end stage failing vascular access, aged 39 to 51 years and with 6 to 13 previous catheter lines, were reviewed retrospectively.The paper identified a minor transient complication, a device repositioning managed as a day case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HERO GRAFT
Type of Device
VASCULAR GRAFT
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer (Section G)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer Contact
sandra o'reilly
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key4733707
MDR Text Key5751314
Report Number1063481-2015-00055
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K124039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/04/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/28/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberHERO 1001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/04/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-